Stockreport

Vir Biotechnology shares surge on news Glaxo taking $250 million stake [MarketWatch]

GlaxoSmithKline PLC  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF U.K. pharmaceutical GlaxoSmithKline said it's making an equity investment in Vir Biotechnology as part of a collaboration to research and develop solutions for coronavir [Read more]